Sunshine Act Meeting Notice, 63732 [E8-25431]

Download as PDF 63732 Federal Register / Vol. 73, No. 208 / Monday, October 27, 2008 / Notices investigative attorney supported the motion. The ALJ issued the subject ID (Order No. 8) on September 26, 2008, amending the complaint and notice of investigation to name Kokido Trading, Ltd. as the proper respondent rather than Kokido, Ltd. The ID also terminated the investigation with respect to Kokido Trading, Ltd. on the basis of a consent order stipulation and proposed consent order. No petitions for review of the ID were filed. The Commission has determined not to review the ID and to issue the proposed consent order. Since Kokido Trading, Ltd. is the last respondent, the investigation is terminated in its entirety. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and Commission rules 210.21, 210.42, 19 CFR 210.21, 210.42. Dated: Issued: October 22, 2008. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E8–25543 Filed 10–24–08; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–08–029] Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: October 30, 2008 at 9:30 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agenda for future meetings: none 2. Minutes 3. Ratification List 4. Inv. Nos. 701–451 and 731–TA– 1126–1127 (Final)(Certain Lightweight Thermal Paper from China and Germany)—briefing and vote. (The Commission is currently scheduled to transmit its determinations and Commissioners’ opinions to the Secretary of Commerce on or before November 10, 2008.) 5. Outstanding action jackets: none In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. mstockstill on PROD1PC66 with NOTICES AGENCY HOLDING THE MEETING: Issued: October 21, 2008. VerDate Aug<31>2005 17:13 Oct 24, 2008 Jkt 217001 By order of the Commission. William R. Bishop, Hearings and Meetings Coordinator. [FR Doc. E8–25431 Filed 10–24–08; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–306F] Final Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2008 Drug Enforcement Administration (DEA), Justice. ACTION: Notice of Final Assessment of Annual Needs for 2008. AGENCY: SUMMARY: This notice establishes the Final Revised 2008 Assessment of Annual Needs for certain List I chemicals in accordance with the Combat Methamphetamine Epidemic Act of 2005 (CMEA), enacted on March 9, 2006. DATES: Effective Date: October 27, 2008. FOR FURTHER INFORMATION CONTACT: Christine A. Sannerud, PhD, Chief, Drug & Chemical Evaluation Section, Drug Enforcement Administration (DEA), Springfield, Virginia 22152, Telephone: (202) 307–7183. SUPPLEMENTARY INFORMATION: Section 713 of the Combat Methamphetamine Epidemic Act of 2005 (Title VII of Pub. L. 109–177) (CMEA) amended Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) by adding ephedrine, pseudoephedrine, and phenylpropanolamine to existing language to read as follows: ‘‘The Attorney General shall determine the total quantity and establish production quotas for each basic class of controlled substance in schedules I and II and for ephedrine, pseudoephedrine, and phenylpropanolamine to be manufactured each calendar year to provide for the estimated medical, scientific, research, and industrial needs of the United States, for lawful export requirements, and for the establishment and maintenance of reserve stocks.’’ Further, 715 of CMEA amended21 U.S.C. 952 ‘‘Importation of controlled substances’’ by adding the same List I chemicals to the existing language in paragraph (a), and by adding a new paragraph (d) to read as follows: (a) Controlled substances in schedule I or II and narcotic drugs in schedule III, IV, or V; exceptions: It shall be unlawful to import into the customs territory of the United States from PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 any place outside thereof (but within the United States), or to import into the United States from any place outside thereof, any controlled substance in schedule I or II of subchapter I of this chapter, or any narcotic drug in schedule III, IV, or V of subchapter I of this chapter, or ephedrine, pseudoephedrine, and phenylpropanolamine, except that— (1) such amounts of crude opium, poppy straw, concentrate of poppy straw, and coca leaves, and of ephedrine, pseudoephedrine, and phenylpropanolamine, as the Attorney General finds to be necessary to provide for medical, scientific, or other legitimate purposes, and * * * (d)(1) With respect to a registrant under section 958 who is authorized under subsection (a)(1) to import ephedrine, pseudoephedrine, or phenylpropanolamine, at any time during the year the registrant may apply for an increase in the amount of such chemical that the registrant is authorized to import, and the Attorney General may approve the application if the Attorney General determines that the approval is necessary to provide for medical, scientific, or other legitimate purposes regarding the chemical. Editor’s Note: This excerpt of the amendment is published for the convenience of the reader. The official text is published at 21 U.S.C. 952(a) and (d)(1). The 2008 Assessment of Annual Needs represents those quantities of ephedrine, pseudoephedrine, and phenylpropanolamine which may be manufactured domestically and/or imported into the United States in 2008 to provide adequate supplies of each chemical for: the estimated medical, scientific, research, and industrial needs of the United States; lawful export requirements; and the establishment and maintenance of reserve stocks. On June 23, 2008, a notice entitled, ‘‘Proposed Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2008’’ was published in the Federal Register (73 FR 35410). This notice proposed the revised 2008 Assessment of Annual Needs for ephedrine (for sale), ephedrine (for conversion), pseudoephedrine (for sale), phenylpropanolamine (for sale) and phenylpropanolamine (for conversion). All interested persons were invited to comment on or object to the proposed assessments on or before July 23, 2008. DEA did not receive any comments or objections to the proposed revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2008. Therefore, under the authority vested in the Attorney General by Section 306 of the CSA (21 U.S.C. 826), and delegated to the Administrator of the DEA by 28 E:\FR\FM\27OCN1.SGM 27OCN1

Agencies

[Federal Register Volume 73, Number 208 (Monday, October 27, 2008)]
[Notices]
[Page 63732]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25431]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-08-029]


Sunshine Act Meeting Notice

Agency Holding the Meeting:  United States International Trade 
Commission.

Time and Date:  October 30, 2008 at 9:30 a.m.

Place:  Room 101, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

Status:  Open to the public.

Matters To Be Considered:
    1. Agenda for future meetings: none
    2. Minutes
    3. Ratification List
    4. Inv. Nos. 701-451 and 731-TA-1126-1127 (Final)(Certain 
Lightweight Thermal Paper from China and Germany)--briefing and vote. 
(The Commission is currently scheduled to transmit its determinations 
and Commissioners' opinions to the Secretary of Commerce on or before 
November 10, 2008.)
    5. Outstanding action jackets: none
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    Issued: October 21, 2008.

    By order of the Commission.
William R. Bishop,
Hearings and Meetings Coordinator.
 [FR Doc. E8-25431 Filed 10-24-08; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.